VS Digital Health To Launch New Nurse Dispatch Service “MobileMedIV.com” Across the US

  • Nurse Dispatch Service will make IV Drip Therapy Bookings faster and easier
  • Customers will have access to top-notch consultation services provided by Registered Nurses, ensuring the highest standard of care
  • MobileMedIV.com will Soft Launch in August 2023, with initial services of Mobile IV Drips (ie. Vitamins, Energy, Immunity, Detox, Anti-Aging) and IV Shots (ie. Vitamin B12, Weight Loss) will be the initial services available during the soft launch period.

VANCOUVER, British Columbia, July 26, 2023 (GLOBE NEWSWIRE) -- Victory Square Technologies Inc. (“Victory Square'') (CSE:VST) (OTC:VSQTF) (FWB:6F6), is pleased to announce that its wholly-owned portfolio company VS Digital Health Inc. (“VS Digital'' or the “Company”) in partnership with portfolio company Hydreight Technologies Inc. ("Hydreight") (TSXV: NURS)(OTCQB: HYDTF)(FSE: SO6) is preparing to launch a new website booking system and market place, supported by a dispatch call centre (the “Dispatch Call Centre”), called “MobileMedIV.com.” MobileMedIV.com will provide customers a streamlined approach to inquire about services offered, receiving consultations and booking appointments for IV therapy and other services.

Through VS Digital’s partnership with Hydreight, the Company has been actively developing and integrating new technologies and innovative applications to create an efficient and robust platform that enhances the accessibility of mobile health. MobileMedIV.com will serve as a user-friendly platform, allowing seamless inquiries and service booking with a Hydreight Business Partner (“Business Partner”). Furthermore, customers will have access to top-notch consultation services provided by Registered Nurses (“RNs”), ensuring the highest standard of care.

MobileMedIV.com Highlights:

  • Introducing an Innovative and Streamlined Approach to Inquiries and Service Bookings with Hydreight Business Partners
    • The Dispatch Call Centre is staffed with a team of highly qualified RNs, dedicated to helping customers find the most suitable services for their unique requirements. Hydreight’s RNs provide expert consultations and efficiently schedule appointments with the nearest available Business Partner. Additionally, inquiries can also be made conveniently through an online chat function or via SMS texting, ensuring seamless communication.
  • MobileMedIV.com will Soft Launch in August 2023, With Initial Services of Mobile IV Drips and IV shots.
    • The company plans to soft launch MobileMedIV.com in August 2023, and expand the range of services being offered by the end of August.
    • IV Drips (ie. Vitamins, Energy, Immunity, Detox, Anti-Aging) and IV Shots (ie. Vitamin B12, Weight Loss) will be the initial services available during the soft launch period.
  • MobileMedIV.com and Dispatch Call Centre
    • In Partnership with Hydreight, the Company has developed a new website and marketplace to revolutionize the way customers access services. The new booking system will enable customers to effortlessly book appointments or contact the Dispatch Call Centre in order to inquire and book any of the services offered by Business Partners who are on the Hydreight premium package.
    • Customers will have access to a Dispatch Call Centre where a team of qualified RNs will be able to assist customers in finding the right services for their specific needs such as drip therapy, and can receive consultations on the spot. The Dispatch Call Centre Team is also able to book appointments with Business Partners located in their respective vicinity so that inquiries can be turned into active customers in one call.

Given the projected growth of the US home healthcare services market, estimated to reach $153.19 billion by 2029 with a CAGR of 7.2% in the forecast period, both companies are well positioned to capitalize on this growing trend and further reinforce their position as market leaders.

Sign up to VST’s official newsletter at www.VictorySquare.com/newsletter

On behalf of the Board of Directors

“Shafin Diamond Tejani”
Director and Chief Executive Officer
Victory Square Technologies Inc.
www.victorysquare.com

For further information about Victory Square, please contact:

Investor Relations Contact – Abbey Vogt
Email: ir@victorysquare.com
Telephone: 604 283-9166

Peter Smyrniotis – Director
Telephone: 604 283-9166

ABOUT VICTORY SQUARE TECHNOLOGIES INC.

Victory Square (VST) builds, acquires and invests in promising startups, then provides the senior leadership and resources needed for fast-track growth. VST’s sweet spot is cutting-edge tech that’s shaping the 4th Industrial Revolution. Our corporate portfolio consists of 25+ global companies using AI, VR/AR, and blockchain to disrupt sectors as diverse as fintech, insurance, health and gaming.

What we do differently for startups

VST isn’t your ordinary investor. With real skin in the game, we’re committed to ensuring each company in our portfolio succeeds. Our secret sauce starts with selecting startups that have real solutions, not just ideas. We pair you with senior talent in product, engineering, customer acquisition and more. Then we let you do what you do best — build, innovate and disrupt. In 24-36 months, you’ll scale and be ready to monetize.

What we do differently for investors

For investors, we offer early-stage access to the next unicorns before they’re unicorns. Our portfolio represents a uniquely liquid and secure way for investors to get access to the latest cutting-edge technologies. Because we focus on market-ready solutions that scale quickly, we’re able to provide strong and stable returns while also tapping into emerging global trends with big upsides.

Victory Square integrates a strong ESG (environmental, social and corporate governance) component throughout its operations. Our portfolio highlights minority entrepreneurs, often overlooked by traditional investors, including many from developing countries. We are also dedicated to giving back to the communities in which we serve and operate. The Company’s mandate is to assist organizations through its time, talent and treasure. The Company is committed to organizations that provide services in the youth, mental health, special needs, sport, tech, education, marginalized groups, First Nations, and accessibility sectors.

VST is a publicly-traded company headquartered in Vancouver, Canada, and listed on the Canadian Securities Exchange (VST), Frankfurt Exchange (6F6) and the OTCQX (VSQTF).

For more information, please visit www.victorysquare.com.

ABOUT THE CANADIAN SECURITIES EXCHANGE (CSE)

The Canadian Securities Exchange, or CSE, is operated by CNSX Markets Inc. Recognized as a stock exchange in 2004, the CSE began operations in 2003 to provide a modern and efficient alternative for companies looking to access the Canadian public capital markets.

FORWARD-LOOKING INFORMATION

This press release contains statements which constitute “forward-looking information” within the meaning of applicable securities laws, including statements regarding the plans, intentions, beliefs and current expectations of the Company with respect to future business activities and operating performance. Forward-looking information is often identified by the words “may”, “would”, “could”, “should”, “will”, “intend”, “plan”, “anticipate”, “believe”, “estimate”, “expect”, “Approximately” or similar expressions and includes information regarding the launch date of MedicalMedIV.com, and the anticipated effect on bookings and customer retention rates. Investors are cautioned that forward-looking information is not based on historical facts but instead reflects the Company’s management’s expectations, estimates or predictions concerning future results or events based on the opinions, assumptions and estimates of management considered reasonable at the date the statements are made. Although the Company believes that the expectations reflected in such forward-looking information are reasonable, such information involves risks and uncertainties, and undue reliance should not be placed on such information, as unknown or unpredictable factors could have material adverse effects on future results, performance or achievements of the Company. Among the key factors that could cause actual results to differ materially from those projected in the forward-looking information are the following: the ability to obtain requisite regulatory and other approvals with respect to the business operated by the Company and/or the potential impact of the listing of the Company’s shares on the CSE on relationships, including with regulatory bodies, employees, suppliers, customers and competitors; changes in general economic, business and political conditions, including changes in the financial markets; changes in applicable laws; compliance with extensive government regulation; and the diversion of management time as a result of being a publicly listed entity. This forward-looking information may be affected by risks and uncertainties in the business of the Company and market conditions.

Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking information prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected. Although the Company has attempted to identify important risks, uncertainties and factors which could cause actual results to differ materially, there may be others that cause results not to be as anticipated, estimated or intended. The Company does not intend, and does not assume any obligation, to update this forward-looking information except as otherwise required by applicable law.

The Canadian Securities Exchange has neither approved nor disapproved the contents of this news release and accepts no responsibility for the adequacy or accuracy hereof.


Primary Logo

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.